Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma.
1997 · PubMed · 95 citations
S
Shinji Tanaka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
452
Papers
9.9K
Citations
53
h-index
191
i10-index
Shinji Tanaka is an academic researcher from Tokyo Institute of Technology. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Hepatocellular Carcinoma Treatment and Prognosis & RNA modifications and cancer. The author has an h-index of 53, co-authored 385 publications.
ORCID: 0000-0002-7718-3453Papers by this author
worksClassification of primary liver cancer with immunosuppression mechanisms and correlation with genomic alterations
2020 · EBioMedicine · 90 citations
https://doi.org/10.1016/j.ebiom.2020.102659
The difficulty of laparoscopic liver resection
2015 · Updates in Surgery · 63 citations
https://doi.org/10.1007/s13304-015-0302-7
Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma
2021 · Scientific Reports · 29 citations
https://doi.org/10.1038/s41598-021-96167-0
Tumor suppressor functions of DAXX through histone H3.3/H3K9me3 pathway in pancreatic NETs
2018 · Endocrine Related Cancer · 21 citations
https://doi.org/10.1530/erc-17-0328
Identification of selective inhibitors for diffuse-type gastric cancer cells by screening of annotated compounds in preclinical models
2018 · British Journal of Cancer · 14 citations
https://doi.org/10.1038/s41416-018-0008-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat